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Table 1 Laboratory findings of immune-mediated thrombocytopenic purpura related to Toxoplasma gondii infection
Variable Period of the toxoplasmosis and immune-mediated thrombocytopenic purpura
Mononucleosis-like Immune purpura 1 week after 1-month follow-up
Hemoglobin (g/dl) 12.0 12.4 11.8 13.4
Hematocrit (%) 36.4 39.3 38.2 43.6
White cell count (109/l) 9.46 6.74 7.74 7.77
Neutrophils (109/l) 4.90 2.40 3.90 4.30
Lymphocytes (109/l) 3.00 3.90 2.20 2.50
Platelets (109/l) 395 5 172 299
C-Reactive protein (mg/l) 29.4 2.58 1.59 0Acknowledgement
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An unusual case of Corynebacterium striatum
endocarditis and a review of the literature
An 83-year-old man was admitted with a 3-day history of
fever and joint pain (mostly knee and shoulder). Over the
previous three weeks he had been treated in the community
with ciprofloxacin for a presumed recurrent urinary tract
infection. He was known to have metastatic prostate cancer
and had developed secondary hyperfibrinolysis syndrome
with an intracerebral bleed from which he had made a good
recovery.
On examination, he was afebrile. His pulse rate was 85 per
minute and his blood pressure was 98/60 mmHg. An ejection
systolic murmur was heard. His knees and shoulders were
tender and hot to the touch. Respiratory and abdominal
examinations were normal. Neurological examination
revealed increased tone in the muscles.Felipe Francisco Tuon
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Polymyalgia rheumatica, polyarthritis, rheumatoid arthri-
tis, and metastatic effects of prostate cancer were consid-
ered in the differential diagnosis. Laboratory studies
revealed elevated urea and creatinine (12.5 mmol/l and
148 mmol/l, respectively), high alkaline phosphatase
(351 U/l), and a markedly elevated C-reactive protein
(CRP) (565 mg/l). He had a mild leukocytosis (11.4  109/l)
and a raised erythrocyte sedimentation rate (74 mm/h).
Tests for rheumatoid factor and anti-neutrophil cytoplasmic
antibody were negative. A chest roentgenogram showed
clear lung fields, but extensive bony sclerosis was noted
consistent with bony metastases.
Four separate sets of blood cultures taken at different
times grew Corynebacterium striatum. In the absence of
definitive laboratory guidelines for determining the antibio-
tic susceptibility of diphtheroids, we established the mini-
mum inhibitory concentrations (MIC) for penicillin,
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Table 1 Summarizing previously reported cases of Corynebacterium striatum endocarditis
Reference Age Sex Associated illness Valve Intervention Outcome
4 76 M None Aortic Medical Died
5 54 M Hypertension Aortic Medical and surgical Survived
6 73 M Pacemaker Tricuspid Medical and surgical Survived
7 24 M Ventricular shunt Pulmonary Medical Survived
8 68 M Hypertension Mitral Medical Survived
9 72 F Prosthetic valve Aortic Medical Died
10 62 F Prosthetic valve Aortic Medical Survived
11 50 M Mycotic aneurysm Aortic Medical and surgical Survived
2 61 F Rheumatic fever Mitral Medical Survived
2 72 F Prosthetic valve Mitral Medical Survived
3 46 F Hemodialysis Tricuspid Medical Survived
12 68 M Prosthetic valve Mitral Medical Survived
13 69 F Endometrial cancer Mitral Medical and surgical Survived
14 77 F None Mitral Medical Survived
15 62 M Hypertension Aortic Medical and surgical Survivedgentamicin, and vancomycin. These values were 1.5 mg/l,
0.032 mg/l, and 0.5 mg/l, respectively. A transthoracic echo-
cardiogram revealed a mobile oscillating mass at the tip of
the mitral valve leaflet. A diagnosis of infective endocarditis
(IE) was made and therapy with vancomycin and rifampin was
instituted.
As the patient showed no signs of improvement despite 5
days of treatment, therapy was switched to intravenous
benzyl penicillin in combination with gentamicin in doses
prescribed for IE. Combination therapy was used because the
MIC of penicillin was considered to be on the higher side.
Penicillin and gentamicin combination is known to be syner-
gistic in the treatment of diphtheroid endocarditis irrespec-
tive of the MIC of penicillin provided the strains are
gentamicin-susceptible.1 However, the patient remained
febrile on this combination although his CRP and total leu-
kocyte count continued to fall. An abdominal CT scan in the
third week of admission was reported as normal. A repeat
echocardiogram at this stage failed to show any vegetation.
Six sets of blood cultures (two while on vancomycin and four
on penicillin) taken on different days after the initiation of
treatment did not grow any pathogens. As there was a
temporal relationship between the administration of peni-
cillin and the fever spikes, b-lactam induced fever was
considered and combination therapy was discontinued fol-
lowing which the patient defervesced. However, since the
therapy for endocarditis was thought to be incomplete at this
point, treatment was switched to intravenous daptomycin
6 mg/kg once daily. The MIC of daptomycin for this strain was
found to be 0.064 mg/l. He remained apyrexial and his
inflammatory markers continued to improve while on dapto-
mycin. An additional blood culture set taken 7 days after
daptomycin was started did not grow any bacteria. Dapto-
mycin was given for a total of 17 days following which the
patient was discharged. Although he appeared to recover
from endocarditis based on his clinical status, repeat echo-
cardiogram findings, and negative microbiology, he died of
myocardial infarction 2 weeks following discharge. Emboli to
the coronary arteries can complicate the course of IE but this
is unlikely to have complicated the present case because of
the long interval between the repeat negative echocardio-
gram and the occurrence of myocardial infarction.A literature search in Medline revealed only 15 reports of
C. striatum endocarditis (Table 1).2—15 In our patient, multi-
ple joint pain coupled with a history of prostate cancer
pointed towards a primary rheumatologic condition or the
effects of metastasis of the primary carcinoma. Prostate
cancer is prone to metastasize in long bones. Repeated
isolation of C. striatum in blood cultures and the subsequent
echocardiogram finding clinched the diagnosis of IE.
IE is associated with immune complexes. Deposition of the
antigen—antibody complexes can give rise to joint manifes-
tations or vasculitis. Stoddart and colleagues reported two
cases of endocarditis due to C. striatum that presented with
symptoms suggestive of vasculitis and systemic sclerosis.2 It is
possible that because diphtheroids are often dismissed as
contaminants even when isolated from sterile sites, the
diagnosis is delayed, thereby allowing a full-blown immu-
nological process to manifest in the absence of antibiotic
treatment. By reducing the number of organisms, antibio-
tics cause a fall in the number of immune complexes.16
Early and specific intervention in IE due to more common
causes may often prevent the onset of severe immunologic
manifestations.
Penicillin and vancomycin have been used for the treat-
ment of diphtheroid endocarditis, but neither was found to
be suitable in our patient. Daptomycin is a rapidly bacter-
icidal lipopeptide antibiotic that is currently licensed in the
UK for severe skin and soft tissue infections and has recently
been licensed in the USA for endocarditis. A recent study
found daptomycin to be useful for right-sided IE caused by
Staphylococcus aureus.17 Its long half-life allows once-daily
administration. The combination of daptomycin and rifampin
has been used in one previously reported case of C. striatum
endocarditis.3 Our patient seemed to respond to daptomycin
monotherapy and completed a total course of 5 weeks of
treatment that included vancomycin, penicillin, and dapto-
mycin.
In summary, patients presenting with features suggestive
of a rheumatologic condition should be thoroughly reviewed
before blood culture isolates are dismissed as contaminants.
In recalcitrant cases of diphtheroid endocarditis, daptomycin
may be a useful alternative for patients who fail to respond to
standard therapy. There is also an urgent need to establish
674 Correspondenceantibiotic susceptibility guidelines for diphtheroids that
would help infectious diseases specialists to choose the most
appropriate antibiotics.
This paper was presented in part at the Scottish Micro-
biology Association meeting, Dunblane, November 11, 2006.
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